Due to the relatively high relapse rate and need for additional therapies, current research is being done on the use of Vedolizumab for the treatment of microscopic colitis.
Although the rise in pediatric obesity predates the COVID-19 pandemic, stressors experienced during the pandemic exposed inequities in children’s health.
Among other considerations, health care providers must avoid giving individual medical advice.
While the causes of gender gaps are often complex and inextricably intertwined, a more in depth approach is needed to identify areas where immediate action can be taken to improve gender equity and diversity in gastroenterology.
A patient presenting with sudden-onset dysphagia and vomiting initially is diagnosed with GERD but does not respond to PPIs. What is your diagnosis?
Unmitigated health disparities remain a persistent challenge throughout gastroenterology practice.
With health experts across the country agreeing we are in the midst of a mental health pandemic, psychiatrist Aaron M. Hawkins, MD offers his view about the current state and the future of mental health in the United States.
The exact pathophysiology of microscopic colitis is not completely understood, though PPIs and NSAIDs are 2 medications commonly implicated for triggering the inflammatory process.
Researchers searched publication databases for studies of the gut-brain connection, migraine, and gastric disorders.
Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.
What is the power of touch and how has it played into the history of clinical treatment as well as our current reality?
In patients with IBD, management of immunosuppressive regimens, as well as safety and efficacy of vaccines, has raised many questions during the COVID-19 pandemic.
Though patient use of cannabinoids for the treatment of IBD has increased, clinical decision making on whether to formally recommend it as treatment remains difficult.
For many health care professionals, successfully managing uncertainty means recognizing that surety is complicated and illusory and knowledge is iterative and provisional rather than definitive.
In today’s feature article, we talk with Ziyad Al-Aly, MD, of the Institute for Public Health in Washington, DC, who describes treating long-haulers as “America’s next big health crisis.”
The decision whether or not to treat patients with portal vein thrombosis is frequently encountered and remains a challenge.
Clinical Pain Advisor met with Scharles Konadu, MD, a member of the American Board of Internal Medicine Gastroenterology Specialty Board, to discuss how deeply racial inequity is woven into our health care system.
The COVID-19 pandemic sheds new light on existing access challenges in preventive health care.
The American Gastroenterological Association (AGA) has issued a clinical practice update regarding bariatric surgery in cirrhosis.
Initiation of opioid use during a flare of symptoms can eventually lead to chronic opioid use (COU), which can have detrimental effects on a patient’s IBD, as well as their overall clinical health.